SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001372514-23-000110
Filing Date
2023-07-21
Accepted
2023-07-21 16:49:52
Documents
8
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A kiora-definitiveproxyxspec.htm DEF 14A 607077
2 GRAPHIC chart-c44974cf8915490990f.jpg GRAPHIC 72353
3 GRAPHIC image_20.jpg GRAPHIC 115
4 GRAPHIC image_4.jpg GRAPHIC 115
5 KIORA LOGO kioralogo.jpg GRAPHIC 36955
6 KIORA LOGO logo.jpg GRAPHIC 20251
7 PROXYCARD2 proxycard_prelim-pg2.jpg GRAPHIC 83007
8 PROXYCARD1 proxycard_prelim.jpg GRAPHIC 97090
  Complete submission text file 0001372514-23-000110.txt   1035967
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36672 | Film No.: 231103012
SIC: 2834 Pharmaceutical Preparations